Literature DB >> 11227030

Susceptibility of LDL to oxidative modification in healthy volunteers supplemented with low doses of n-3 polyunsaturated fatty acids.

S Higgins1, Y L Carroll, S N McCarthy, B M Corridan, H M Roche, J M Wallace, N M O'Brien, P A Morrissey.   

Abstract

The objective of the present study was to evaluate the oxidative susceptibility of LDL in human volunteers following supplementation with various low doses (<1 g/d) of n-3 polyunsaturated fatty acids (PUFA). Sixty-two healthy volunteers (thirty-seven males and twenty-five females, aged 19-63 years) were recruited to take part in a randomised placebo-controlled trial. Volunteers were required to take 0.9, 0.6 or 0.3 g n-3 PUFA as fish oil or placebo capsules daily for 16 weeks. Susceptibility of LDL to oxidative modification was assessed by measuring the production of conjugated dienes and thiobarbituric acid-reactive substances in LDL oxidised by Cu2+ (15 microM) or 2,2'-azobis(2-amidinopropane) dihydrochloride (1 mM) for 5 h. Plasma fatty acid and LDL-fatty acid composition, cholesterol levels and antioxidant concentrations were also measured. While post-treatment n-3 PUFA compositions of plasma and LDL reflected the capsule contents, no meaningful differences in antioxidant concentrations or cholesterol levels were observed between the groups. Supplementation with low doses of n-3 PUFA as fish oil did not influence the oxidative susceptibility of LDL. The results of the present study suggest that moderate dietary intakes of n-3 PUFA do not significantly influence the susceptibility of LDL to oxidative modification in vitro.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11227030     DOI: 10.1079/bjn2000220

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  8 in total

1.  Broader and safer clinically-relevant activities of pentadecanoic acid compared to omega-3: Evaluation of an emerging essential fatty acid across twelve primary human cell-based disease systems.

Authors:  Stephanie K Venn-Watson; Camden N Butterworth
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

2.  n-3 long-chain FA decrease serum levels of TG and remnant-like particle-cholesterol in humans.

Authors:  Kei Hamazaki; Miho Itomura; Mingming Huan; Hiroto Nishizawa; Shiro Watanabe; Tomohito Hamazaki; Shigeki Sawazaki; Katsutoshi Terasawa; Shuuji Nakajima; Takashi Terano; Yoshiya Hata; Seiichi Fujishiro
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

Review 3.  Omega-3 fatty acids: how can they be used in secondary prevention?

Authors:  Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Curr Atheroscler Rep       Date:  2008-12       Impact factor: 5.113

4.  Effect of EPA and vitamin C on superoxide dismutase, glutathione peroxidase, total antioxidant capacity and malondialdehyde in type 2 diabetic patients.

Authors:  Mohammad Mehdi Shakouri Mahmoudabadi; Ali Reza Rahbar
Journal:  Oman Med J       Date:  2014-01

Review 5.  The beneficial effects of nutraceuticals and natural products on small dense LDL levels, LDL particle number and LDL particle size: a clinical review.

Authors:  Sepide Talebi; Mohammad Bagherniya; Stephen L Atkin; Gholamreza Askari; Hossein M Orafai; Amirhossein Sahebkar
Journal:  Lipids Health Dis       Date:  2020-04-11       Impact factor: 3.876

6.  Effects of EPA and Vitamin E on Serum Enzymatic Antioxidants and Peroxidation Indices in Patients with Type II Diabetes Mellitus.

Authors:  Sh Sarbolouki; M Djalali; Ar Dorosty; Sa Djazayery; Mr Eshraghian; Sar Ebadi; Sb Hashemi
Journal:  Iran J Public Health       Date:  2010-09-30       Impact factor: 1.429

7.  Valproate-induced liver injury: modulation by the omega-3 fatty acid DHA proposes a novel anticonvulsant regimen.

Authors:  Marwa A Abdel-Dayem; Ahmed A Elmarakby; Azza A Abdel-Aziz; Chelsey Pye; Shehta A Said; Abdalla M El-Mowafy
Journal:  Drugs R D       Date:  2014-06

8.  Effect of Low Dose Docosahexaenoic Acid-Rich Fish Oil on Plasma Lipids and Lipoproteins in Pre-Menopausal Women: A Dose⁻Response Randomized Placebo-Controlled Trial.

Authors:  Cassandra Sparkes; Robert Gibson; Andrew Sinclair; Paul L Else; Barbara J Meyer
Journal:  Nutrients       Date:  2018-10-08       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.